MMPAD Munich Meeting Report

MEETING REPORT 19 European Roadshow - Friday 25 th May, 2018 Munich, Germany REFERENCES 1. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what’s next? Diabetes 2010; 59: 1561-71. 2. International Society for Pediatric and Adolescent Diabetes (ISPAD). ISPAD Clinical Practice Consensus Guidelines 2014. Pediatr Diabetes 2014; 15 (Suppl 20). 3. Fritsch M, Schober E, Rami-Merhar B, et al. Diabetic ketoacidosis at diagnosis in Austrian children: a population- based analysis, 1989-2011. J Pediatr 2013; 163: 1484-8. 4. Wolfsdorf JI, Glaser N, Agus M, et al. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Consensus Statement from the International Society for Pediatric and Adolescent Diabetes. Pediatr Diabetes 2018 ; [Epub ahead of print]. 5. Deutsche Diabetes Gesellschaft (DDG). Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter - Aktualisierung 2015. AWMF-Registernummer 057–016. 6. International Diabetes Federation (IDF) and International Society for Pediatric and Adolescent Diabetes (ISPAD). Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence. Brussels; IDF: 2011. 7. Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near- patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2007; 8: 150-6. 8. Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89: 188-94. 9. Jones GC, Timmons JG, Cunningham SG, et al. Hypoglycemia and Clinical Outcomes in Hospitalized Patients With Diabetes: Does Association With Adverse Outcomes Remain When Number of Glucose Tests Performed Is Accounted For? J Diabetes Sci Technol 2017; 11: 720-3. 10. Karges B, Kapellen T, Wagner VM, et al. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes 2017; 18: 51-8. 11. Haynes A, Hermann JM, Miller KM, et al. Severe hypoglycemia rates are not associated with HbA1c: a cross- sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes 2017; 18: 643-50. 12. Raile K, Galler A, Hoefer S, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007; 30: 2523-8. 13. Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2017; 102: 4343-4410. 14. Nordwall M, Arngvist HJ, Bojestig M, et al. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study. Pediatr Diabetes 2009; 10: 168-76. 15. Nordwall M, Abrahamsson M, Dhir M, et al. Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015; 38: 308-15. 16. Danne T, Phillip M, Buckingham B, et al. ISPAD Clinical Practice Consensus Guidelines 2018 Compendium Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2018; doi: 10.1111/pedi.12718. 17. Sherr J, Tauschmann M, Battelino T, et al. ISPAD guidelines - Diabetes Technologies Chapter. ISPAD; 2018. 18. Danne T, Nimri R, Battelino T, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-40. 19. Thordarson H and Søvik O. Dead in Bed Syndrome in Young Diabetic Patients in Norway. Diabet Med 1995; 12: 782-7. 20. Hseih A and Twigg SM. The enigma of the dead-in-bed syndrome: challenges in predicting and preventing this devastating complication of type 1 diabetes. J Diabetes Complications 2014; 28: 585-7. 21. Karges B, Schwandt A, Heidtmann B, et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 2017; 318: 1358-66. 22. Biester T, Kordonouri O, Holder M, et al. ”Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor- Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Diabetes Technol Ther 2017; 19: 173-82. 23. Philip M, Battelino T, Atlas E, et al. Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp. N Engl J Med 2013; 368: 824-33.